Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

Patients with solid tumours are at risk of impaired bone health from metastases and cancer
therapy-induced bone loss (CTIBL). We review medical management of bone health in …

The Medication-Related Osteonecrosis of Jaws (MRONJ) diagnosis process and its
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …

This paper reports on the conclusions of two workshops held in Copenhagen in September
2017 and November 2018 focused on medication-related osteonecrosis of the jaws …

This study investigated the incidence, risk factors, and outcome of medication-related
osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents …

Osteonecrosis of the jaw is a condition in which bone cells die due to various causes. It is
classified as drug-induced jaw osteonecrosis, osteoradionecrosis, traumatic, non-traumatic …

Purpose Medication-related osteonecrosis of the jaw (MRONJ) is a rare but severe adverse
event of antiresorptive agents. However, the precise prevalence and factors associated with …

Osteoporosis is a chronical, systemic skeletal disorder characterized by an increase in bone
resorption, which leads to reduced bone density. The reduction in bone mineral density and …

Medication-related osteonecrosis of the jaw (MRONJ) is defined by the American
Association of Oral and Maxillofacial Surgeons (AAOMS) as the presence of an exposed …

Objective We reported the alveolar bone histology prior to dental extractions in cancer
patients, who received bone‐targeting agents (BTA). Subjects and Methods Fifty‐four …